Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases
- 4 August 2009
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 455 (2) , 125-132
Abstract
Neuroendocrine differentiation in non-small cell lung cancer is a common feature, which has caused contradictory conclusions concerning survival estimates and responsiveness to therapy. Aiming to clarify this conflict, we analyzed neuroendocrine differentiation by immunohistochemistry in 405 surgically resected non-small cell lung carcinomas using standardized tissue microarray platform and the currently recommended antibody panel consisting of chromogranin-A, synaptophysin, and neural-cell adhesion molecule. Diagnostic criteria provided by the World Health Organization were applied. Histological subtypes were primarily reclassified according to current guidelines, assisted by auxiliary immunohistochemistry. Extensive clinical data was acquired, enabling detailed clinicopathological correlation. Importantly, neuroendocrine differentiation assessed by immunohistochemistry showed no significant relation to overall survival estimates, which remained unaffected by histological subtype, neuroendocrine marker type, adjuvant therapy, and recurring disease. The only exception was a small group consisting of three large cell carcinomas, each expressing all three neuroendocrine markers and demonstrating decreased survival. In conclusion, additional immunohistochemical detection of neuroendocrine differentiation in non-small cell lung cancer is presently not of prognostic importance and does not justify a distinct consideration.Keywords
This publication has 22 references indexed in Scilit:
- Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implicationsJournal of Cancer Research and Clinical Oncology, 2009
- Expertenempfehlung 2006 zur rationalen Zweitlinien-Therapie beim nicht-kleinzelligen BronchuskarzinomWiener klinische Wochenschrift, 2007
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic CurveAmerican Journal of Epidemiology, 2006
- Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the LungJournal of Clinical Oncology, 2005
- Tissue microarray technology: principles, pitfalls and perspectives—lessons learned from hematological malignanciesExperimental Gerontology, 2005
- Neuroendocrine differentiation in non‐small cell lung cancer and its relation to prognosis and therapyHistopathology, 2005
- Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor TissuesJournal of Histochemistry & Cytochemistry, 2004
- Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinomaCancer, 2003
- Morphometry Confirms the Presence of Considerable Nuclear Size Overlap Between “Small Cells” and “Large Cells” in High-Grade Pulmonary Neuroendocrine NeoplasmsAmerican Journal of Clinical Pathology, 2001